Sanofi Consumer Healthcare Fair Value
Sanofi Consumer Healthcare (SANOFICONR) average fair value is ₹715.27 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹4763.9 (-84.99%), fair value range ₹118.7–₹1346.25. For live price and a broader fundamental view, visit Sanofi Consumer Healthcare share price today.
Fair Value Analysis Export
SANOFICONR Fair Value vs Current Price — Valuation Summary
SANOFICONR average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. Review SANOFICONR P/E comparison to evaluate earnings-based valuation against sector peers.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
SANOFICONR Fair Value Analysis — Data Sources & Coverage
Sanofi Consumer Healthcare financial data sources, valuation methods applied and sector benchmarks used — 2024 financial year. Also explore SANOFICONR share price history to track price trends across different timeframes.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is 2 years old (2024).
SANOFICONR vs Healthcare Sector Peers — P/E, P/B & Market Cap
Sanofi Consumer Healthcare P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Accretion Pharmaceuticals | ACCPL | 16.94 | 2.55 | ₹115 |
| Jeena Sikho Lifecare | JSLL | 41.45 | 23.68 | ₹8,396 |
| Par Drugs & Chemical | PAR | 8.09 | 1.06 | ₹113 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Sat Kartar Life | SATKARTAR | 32.1 | 6.11 | ₹320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.